US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ARS PHARMACEUTICALS INC

5.35

-0.1550-2.82%

Post-market: 5.350.00000.00%19:55 EDT

Volume:1.94M

Turnover:10.30M

Market Cap:532.04M

PE:-2.46

High:5.46

Open:5.40

Low:5.20

Close:5.51

52wk High:14.00

52wk Low:4.91

Shares:99.45M

Float Shares:48.03M

Volume Ratio:1.07

T/O Rate:4.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1757

EPS(LYR):-1.7400

ROE:-210.35%

ROA:-48.02%

PB:42.52

PE(LYR):-3.07

Loading ...

Overview Company News Filings

ARS Pharmaceuticals Inc - Expect to File for Neffy 1 Mg Approval for Children 15-30 Kg in Canada by Summer

THOMSON REUTERS

Neffy® (Epinephrine Nasal Spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (Anaphylaxis)

THOMSON REUTERS

Analysts Are Bullish on These Healthcare Stocks: ARS Pharmaceuticals (SPRY), Longeveron (LGVN)

ARS Pharmaceuticals Inc : Northland Capital Initiates Coverage With Outperform Rating; Target Price $25

THOMSON REUTERS

U.S. RESEARCH ROUNDUP-Comstock Resources, Trustmark, Viasat

ARS Gets FDA Approval to Remove Age Requirement for Allergic-Reaction Nasal Spray

ARS Pharmaceuticals receives FDA approval to remove neffy 1 mg age requirement

BRIEF-Ars Pharmaceuticals Receives FDA Approval To Remove Age Requirement From Neffy® 1 Mg (Epinephrine Nasal Spray) Label

ARS Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

BRIEF-ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

ARS Pharmaceuticals Reports Q4 Net Loss

MT Newswires Live

Earnings Flash (SPRY) ARS Pharmaceuticals Posts Q4 Net Loss $0.42 a Share, vs. FactSet Est of $0.39 Loss

MT Newswires Live

ARS Pharmaceuticals Q4 revenue beats expectations on strong neffy sales

ARS Pharmaceuticals FY2025 net product revenue rose 895% to USD 72.19 million as net loss widened to USD 171.3 million

ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on Neffy® (Epinephrine Nasal Spray) Commercialization

THOMSON REUTERS

ARS Pharmaceuticals Inc: Neffy Delivers $72.2 Mln of U.S. Net Product Revenue in First Full Year

THOMSON REUTERS

ARS Pharmaceuticals Inc - ARS Pharma to Expand Sales Force From 106 to 150 Beginning Q2 2026

THOMSON REUTERS

ARS Pharmaceuticals Inc - Regulatory Approval for Neffy in Canada Expected Q2 2026, Launch Expected Later in 2026

THOMSON REUTERS

ARS Pharmaceuticals Q4 Revenue USD 28.1 Million VS. Ibes Estimate USD 25.6 Million

THOMSON REUTERS

Press Release: ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy(R) (epinephrine nasal spray) Commercialization

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/SPRY/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","market":"US","secType":"STK","nameCN":"ARS PHARMACEUTICALS INC","latestPrice":5.35,"timestamp":1787601600000,"preClose":5.505,"halted":0,"volume":1936733,"hourTrading":{"tag":"盘后","latestPrice":5.35,"preClose":5.35,"latestTime":"19:55 EDT","volume":1515,"amount":8105.64,"timestamp":1787615710665,"change":0,"changeRate":0,"amplitude":0.015888},"delay":0,"changeRate":-0.028156221616712124,"floatShares":48034500,"shares":99447343,"eps":-2.175701,"marketStatus":"Closed","change":-0.155,"latestTime":"08-24 16:00:00 EDT","open":5.4,"high":5.46,"low":5.2,"amount":10302784.311576,"amplitude":0.04723,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.175701,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"listingDate":1607058000000,"exchange":"NASDAQ","adjPreClose":5.505,"preHourTrading":{"tag":"盘前","latestPrice":5.38,"preClose":5.505,"latestTime":"09:28 EDT","volume":1060,"amount":5737.909001999999,"timestamp":1787578087159,"change":-0.125,"changeRate":-0.022707,"amplitude":0.025141},"postHourTrading":{"tag":"盘后","latestPrice":5.35,"preClose":5.35,"latestTime":"19:55 EDT","volume":1515,"amount":8105.64,"timestamp":1787615710665,"change":0,"changeRate":0,"amplitude":0.015888},"volumeRatio":1.070625,"impliedVol":1.3384,"impliedVolPercentile":0.8127},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","floatShares":48034500,"roa":"-48.02%","roe":"-210.35%","lyrEps":-1.74,"volumeRatio":1.070625,"shares":99447343,"dividePrice":0,"high":5.46,"amplitude":0.04723,"preClose":5.505,"low":5.2,"week52Low":4.9102,"pbRate":"42.52","psRate":"4.55","week52High":13.9987,"institutionHeld":0,"latestPrice":5.35,"eps":-2.175701,"divideRate":0,"volume":1936733,"delay":0,"ttmEps":-2.175701,"open":5.4,"prevYearClose":11.65,"prevWeekClose":5.505,"prevMonthClose":5.13,"prevQuarterClose":8.01,"fiveDayClose":6.24,"twentyDayClose":5.76,"sixtyDayClose":9.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPRY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"SPRY","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.63},{"market":"US","date":"2026-05-15","symbol":"SPRY","fiscalQuarterEnding":"2026/03","expectedEps":-0.53,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-0.61},{"market":"US","date":"2026-03-09","symbol":"SPRY","fiscalQuarterEnding":"2025/12","expectedEps":-0.42,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773028800000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2025-11-10","symbol":"SPRY","fiscalQuarterEnding":"2025/09","expectedEps":-0.45,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2025-08-13","symbol":"SPRY","fiscalQuarterEnding":"2025/06","expectedEps":-0.41,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.46}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPRY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0.25,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1775966400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPRY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPRY","date":"2026-08-21","current":-2.458978,"percent":0.958425,"low":-115.157754,"twenty":-28.534893,"median":-16.6288,"eighty":-7.404552,"high":184.020638,"avg":-15.30504,"sd":44.472873,"marketCap":547457623},"quantilePoints":[{"date":"2022-11-11","current":-28.534516,"twenty":-28.349227,"median":-28.071294,"eighty":-27.904534,"marketCap":577624216},{"date":"2022-11-18","current":-27.515427,"twenty":-28.349227,"median":-28.00181,"eighty":-27.867476,"marketCap":556994780},{"date":"2022-11-25","current":-28.627161,"twenty":-29.164499,"median":-28.302905,"eighty":-27.978649,"marketCap":579499619},{"date":"2022-12-02","current":-32.332942,"twenty":-29.813011,"median":-28.534516,"eighty":-27.978649,"marketCap":654515751},{"date":"2022-12-09","current":-33.352032,"twenty":-32.629404,"median":-28.951417,"eighty":-27.987913,"marketCap":675145188},{"date":"2022-12-16","current":-37.428392,"twenty":-33.870842,"median":-29.970507,"eighty":-28.034236,"marketCap":757662933},{"date":"2022-12-23","current":-37.428392,"twenty":-36.761351,"median":-31.221208,"eighty":-28.136145,"marketCap":757662933},{"date":"2022-12-30","current":-39.512894,"twenty":-37.428392,"median":-32.842487,"eighty":-28.39555,"marketCap":799859507},{"date":"2023-01-06","current":-33.490999,"twenty":-37.558094,"median":-33.236227,"eighty":-28.506723,"marketCap":677958292},{"date":"2023-01-13","current":-34.510089,"twenty":-37.428392,"median":-33.352032,"eighty":-28.608632,"marketCap":698587729},{"date":"2023-01-20","current":-24.704541,"twenty":-37.261632,"median":-32.981454,"eighty":-28.089644,"marketCap":627322403},{"date":"2023-01-27","current":-23.338221,"twenty":-36.955904,"median":-32.518231,"eighty":-27.978649,"marketCap":592627442},{"date":"2023-02-03","current":-26.292426,"twenty":-36.631648,"median":-30.109473,"eighty":-26.233342,"marketCap":667643574},{"date":"2023-02-10","current":-28.323442,"twenty":-36.44636,"median":-29.576768,"eighty":-26.233342,"marketCap":719217165},{"date":"2023-02-17","current":-31.868488,"twenty":-36.103575,"median":-29.970507,"eighty":-27.026227,"marketCap":809236523},{"date":"2023-02-24","current":-30.539096,"twenty":-35.51065,"median":-30.109473,"eighty":-27.543213,"marketCap":775479264},{"date":"2023-03-03","current":-33.641011,"twenty":-34.760229,"median":-30.612951,"eighty":-27.668279,"marketCap":854246203},{"date":"2023-03-10","current":-29.025066,"twenty":-34.306271,"median":-30.649879,"eighty":-27.867476,"marketCap":737033496},{"date":"2023-03-17","current":-31.056082,"twenty":-33.963486,"median":-30.631415,"eighty":-27.978649,"marketCap":788607087},{"date":"2023-03-24","current":-20.659679,"twenty":-33.801144,"median":-30.612951,"eighty":-27.867476,"marketCap":716518982},{"date":"2023-03-31","current":-17.719962,"twenty":-33.618064,"median":-30.576023,"eighty":-26.2038,"marketCap":614563712},{"date":"2023-04-06","current":-15.732931,"twenty":-33.565575,"median":-30.176574,"eighty":-25.70897,"marketCap":545649501},{"date":"2023-04-14","current":-16.631178,"twenty":-33.492841,"median":-29.970507,"eighty":-24.113699,"marketCap":576802501},{"date":"2023-04-21","current":-17.973502,"twenty":-33.463206,"median":-29.344076,"eighty":-23.419462,"marketCap":623356984},{"date":"2023-04-28","current":-17.210989,"twenty":-33.352032,"median":-29.090384,"eighty":-19.070054,"marketCap":596911536},{"date":"2023-05-05","current":-16.693286,"twenty":-33.350744,"median":-28.918758,"eighty":-18.073817,"marketCap":578956528},{"date":"2023-05-12","current":-12.329028,"twenty":-33.323434,"median":-28.627161,"eighty":-17.841072,"marketCap":427595344},{"date":"2023-05-19","current":-17.294264,"twenty":-33.212652,"median":-28.359496,"eighty":-17.789501,"marketCap":733155735},{"date":"2023-05-26","current":-17.057707,"twenty":-33.123305,"median":-28.101877,"eighty":-17.789501,"marketCap":723127390},{"date":"2023-06-02","current":-15.358643,"twenty":-33.120421,"median":-28.024971,"eighty":-17.719962,"marketCap":651098973},{"date":"2023-06-09","current":-15.179795,"twenty":-32.981454,"median":-27.978649,"eighty":-17.665522,"marketCap":643517035},{"date":"2023-06-16","current":-13.525443,"twenty":-32.939388,"median":-27.584891,"eighty":-17.230009,"marketCap":573384103},{"date":"2023-06-23","current":-14.352619,"twenty":-32.898926,"median":-26.292426,"eighty":-16.984823,"marketCap":608450569},{"date":"2023-06-30","current":-14.777385,"twenty":-32.852687,"median":-26.033933,"eighty":-16.443167,"marketCap":626457673},{"date":"2023-07-07","current":-14.374975,"twenty":-32.778571,"median":-25.664657,"eighty":-16.200645,"marketCap":609398311},{"date":"2023-07-14","current":-15.381,"twenty":-32.650157,"median":-24.815323,"eighty":-15.896248,"marketCap":652046716},{"date":"2023-07-20","current":-16.342312,"twenty":-32.522678,"median":-23.947525,"eighty":-15.738555,"marketCap":692799635},{"date":"2023-07-28","current":-14.889165,"twenty":-32.268091,"median":-23.449004,"eighty":-15.666005,"marketCap":631196385},{"date":"2023-08-04","current":-15.649273,"twenty":-31.980646,"median":-22.434463,"eighty":-15.664922,"marketCap":663419624},{"date":"2023-08-11","current":-12.27233,"twenty":-31.772476,"median":-20.321699,"eighty":-15.577733,"marketCap":654642902},{"date":"2023-08-18","current":-12.05734,"twenty":-31.358888,"median":-18.902086,"eighty":-15.443597,"marketCap":643174706},{"date":"2023-08-25","current":-12.361909,"twenty":-31.218563,"median":-18.499284,"eighty":-15.287104,"marketCap":659421318},{"date":"2023-08-30","current":-12.70231,"twenty":-31.152094,"median":-18.359623,"eighty":-15.152968,"marketCap":677579296},{"date":"2023-09-08","current":-13.114373,"twenty":-31.100395,"median":-18.231502,"eighty":-15.005417,"marketCap":699560007},{"date":"2023-09-15","current":-13.04271,"twenty":-31.033926,"median":-18.031385,"eighty":-14.777385,"marketCap":695737274},{"date":"2023-09-20","current":-11.833393,"twenty":-31.022847,"median":-18.002563,"eighty":-14.750557,"marketCap":631228667},{"date":"2023-09-27","current":-6.718429,"twenty":-31.011769,"median":-17.988032,"eighty":-14.670075,"marketCap":358381151},{"date":"2023-10-05","current":-7.166324,"twenty":-30.867751,"median":-17.964938,"eighty":-14.419687,"marketCap":382273228},{"date":"2023-10-13","current":-6.718429,"twenty":-30.668342,"median":-17.875755,"eighty":-14.196126,"marketCap":358381151},{"date":"2023-10-20","current":-6.055544,"twenty":-30.649879,"median":-17.782874,"eighty":-14.047454,"marketCap":323020877},{"date":"2023-10-27","current":-6.306365,"twenty":-30.649879,"median":-17.728408,"eighty":-14.012806,"marketCap":336400440},{"date":"2023-11-03","current":-6.539271,"twenty":-30.635108,"median":-17.710569,"eighty":-13.713234,"marketCap":348824320},{"date":"2023-11-10","current":-5.319172,"twenty":-30.612951,"median":-17.665522,"eighty":-13.225451,"marketCap":327799293},{"date":"2023-11-17","current":-7.025405,"twenty":-30.612951,"median":-17.36121,"eighty":-12.859969,"marketCap":432947606},{"date":"2023-11-24","current":-7.41484,"twenty":-30.59818,"median":-17.220775,"eighty":-12.627063,"marketCap":456946919},{"date":"2023-12-01","current":-7.523882,"twenty":-30.480012,"median":-17.057707,"eighty":-12.494486,"marketCap":463666727},{"date":"2023-12-08","current":-8.1314,"twenty":-30.216835,"median":-16.553813,"eighty":-12.335604,"marketCap":501105655},{"date":"2023-12-15","current":-8.115823,"twenty":-30.090944,"median":-16.431736,"eighty":-12.243664,"marketCap":500145682},{"date":"2023-12-22","current":-7.944471,"twenty":-30.007565,"median":-16.309818,"eighty":-8.996418,"marketCap":489585985},{"date":"2023-12-29","current":-8.770073,"twenty":-29.979771,"median":-16.222884,"eighty":-8.287174,"marketCap":540464528},{"date":"2024-01-05","current":-8.785651,"twenty":-29.917293,"median":-16.174641,"eighty":-8.399331,"marketCap":541424501},{"date":"2024-01-12","current":-9.112776,"twenty":-29.704533,"median":-16.005127,"eighty":-8.58626,"marketCap":561583924},{"date":"2024-01-19","current":-9.471056,"twenty":-29.440705,"median":-15.977907,"eighty":-8.629876,"marketCap":583663292},{"date":"2024-01-26","current":-10.156461,"twenty":-29.180978,"median":-15.857321,"eighty":-8.707763,"marketCap":625902083},{"date":"2024-02-02","current":-9.969533,"twenty":-29.156298,"median":-15.732931,"eighty":-8.773189,"marketCap":614382412},{"date":"2024-02-09","current":-10.109729,"twenty":-29.07732,"median":-15.682807,"eighty":-8.798113,"marketCap":623022165},{"date":"2024-02-16","current":-11.309188,"twenty":-29.025066,"median":-15.649273,"eighty":-8.900923,"marketCap":696940049},{"date":"2024-02-23","current":-11.83882,"twenty":-29.025066,"median":-15.515136,"eighty":-9.112776,"marketCap":729579115},{"date":"2024-03-01","current":-13.038279,"twenty":-28.81245,"median":-15.453657,"eighty":-9.20624,"marketCap":803496999},{"date":"2024-03-08","current":-13.941768,"twenty":-28.8035,"median":-15.381,"eighty":-9.20624,"marketCap":859175405},{"date":"2024-03-15","current":-14.019655,"twenty":-28.627161,"median":-15.258041,"eighty":-9.237395,"marketCap":863975268},{"date":"2024-03-22","current":-15.975609,"twenty":-28.534516,"median":-15.179795,"eighty":-9.252972,"marketCap":868513986},{"date":"2024-03-28","current":-17.679674,"twenty":-28.423343,"median":-15.269219,"eighty":-9.315282,"marketCap":961155477},{"date":"2024-04-05","current":-16.916395,"twenty":-28.337864,"median":-15.369822,"eighty":-9.405631,"marketCap":919659809},{"date":"2024-04-12","current":-16.401625,"twenty":-28.264358,"median":-15.43689,"eighty":-9.46171,"marketCap":891674358},{"date":"2024-04-19","current":-14.981571,"twenty":-28.131419,"median":-15.49278,"eighty":-9.483518,"marketCap":814473115},{"date":"2024-04-26","current":-14.360297,"twenty":-28.077411,"median":-15.403356,"eighty":-9.636176,"marketCap":780697571},{"date":"2024-05-03","current":-16.860498,"twenty":-28.034236,"median":-15.420123,"eighty":-9.72341,"marketCap":916620967},{"date":"2024-05-10","current":-17.157732,"twenty":-27.987913,"median":-15.505955,"eighty":-9.779488,"marketCap":852670667},{"date":"2024-05-17","current":-17.742813,"twenty":-27.978649,"median":-15.537492,"eighty":-9.809086,"marketCap":881746829},{"date":"2024-05-24","current":-17.157885,"twenty":-27.978649,"median":-15.649273,"eighty":-9.876069,"marketCap":852678252},{"date":"2024-05-31","current":-17.313866,"twenty":-27.867476,"median":-15.716341,"eighty":-9.910338,"marketCap":860429873},{"date":"2024-06-07","current":-17.177383,"twenty":-27.668279,"median":-15.746992,"eighty":-9.932147,"marketCap":853647205},{"date":"2024-06-14","current":-16.884919,"twenty":-27.543213,"median":-15.872834,"eighty":-9.957071,"marketCap":839112916},{"date":"2024-06-21","current":-15.929536,"twenty":-27.026227,"median":-15.872834,"eighty":-9.981995,"marketCap":791634241},{"date":"2024-06-28","current":-16.592455,"twenty":-26.233342,"median":-15.857321,"eighty":-10.038073,"marketCap":824578628},{"date":"2024-07-05","current":-17.742813,"twenty":-26.122559,"median":-15.901185,"eighty":-10.097267,"marketCap":881746829},{"date":"2024-07-12","current":-22.129772,"twenty":-26.004391,"median":-15.977907,"eighty":-10.112844,"marketCap":1099761155},{"date":"2024-07-19","current":-20.550467,"twenty":-25.84191,"median":-16.008119,"eighty":-10.131537,"marketCap":1021275998},{"date":"2024-07-26","current":-21.408361,"twenty":-25.598187,"median":-16.06602,"eighty":-10.234348,"marketCap":1063909910},{"date":"2024-08-02","current":-19.302621,"twenty":-25.251068,"median":-16.155521,"eighty":-10.620668,"marketCap":959263034},{"date":"2024-08-09","current":-23.520911,"twenty":-24.881793,"median":-16.206368,"eighty":-10.941562,"marketCap":1054724705},{"date":"2024-08-16","current":-28.81744,"twenty":-25.84191,"median":-16.286222,"eighty":-11.035026,"marketCap":1292231647},{"date":"2024-08-23","current":-28.017556,"twenty":-27.270827,"median":-16.393243,"eighty":-11.081758,"marketCap":1256363252},{"date":"2024-08-30","current":-28.060793,"twenty":-27.941591,"median":-16.401625,"eighty":-11.197031,"marketCap":1258302084},{"date":"2024-09-06","current":-24.558599,"twenty":-27.79336,"median":-16.442915,"eighty":-11.309188,"marketCap":1101256678},{"date":"2024-09-13","current":-28.752585,"twenty":-27.79336,"median":-16.472628,"eighty":-11.620736,"marketCap":1289323399},{"date":"2024-09-20","current":-31.930502,"twenty":-27.995938,"median":-16.576918,"eighty":-11.620736,"marketCap":1431827564},{"date":"2024-09-27","current":-30.95767,"twenty":-28.060793,"median":-16.631178,"eighty":-11.714201,"marketCap":1388203840},{"date":"2024-10-04","current":-30.67663,"twenty":-28.212122,"median":-16.751589,"eighty":-11.833393,"marketCap":1375601431},{"date":"2024-10-11","current":-31.39004,"twenty":-28.39555,"median":-16.860498,"eighty":-11.83882,"marketCap":1407592162},{"date":"2024-10-18","current":-34.567957,"twenty":-28.752585,"median":-16.884919,"eighty":-11.967761,"marketCap":1550096327},{"date":"2024-10-25","current":-31.930502,"twenty":-28.968769,"median":-17.021402,"eighty":-12.05734,"marketCap":1431827564},{"date":"2024-11-01","current":-32.989808,"twenty":-29.172776,"median":-17.10772,"eighty":-12.236498,"marketCap":1479328953},{"date":"2024-11-08","current":-36.837898,"twenty":-29.53085,"median":-17.177383,"eighty":-12.27233,"marketCap":1651885017},{"date":"2024-11-15","current":-27.728261,"twenty":-29.574087,"median":-17.203935,"eighty":-12.290246,"marketCap":1361568504},{"date":"2024-11-22","current":-27.708469,"twenty":-29.53085,"median":-17.216378,"eighty":-12.329028,"marketCap":1360596650},{"date":"2024-11-29","current":-28.717849,"twenty":-29.510269,"median":-17.294264,"eighty":-12.329028,"marketCap":1410161242},{"date":"2024-12-06","current":-27.748052,"twenty":-29.318167,"median":-17.323614,"eighty":-12.355333,"marketCap":1362540359},{"date":"2024-12-13","current":-23.552198,"twenty":-29.200708,"median":-17.377363,"eighty":-12.390575,"marketCap":1156507152},{"date":"2024-12-20","current":-22.127191,"twenty":-29.174826,"median":-17.429503,"eighty":-12.426406,"marketCap":1086533610},{"date":"2024-12-27","current":-21.355313,"twenty":-29.123341,"median":-17.460097,"eighty":-12.465821,"marketCap":1048631275},{"date":"2025-01-03","current":-22.146983,"twenty":-29.064257,"median":-17.508842,"eighty":-12.501652,"marketCap":1087505465},{"date":"2025-01-10","current":-22.245942,"twenty":-29.025066,"median":-17.556082,"eighty":-12.530317,"marketCap":1092364739},{"date":"2025-01-17","current":-24.878247,"twenty":-29.013807,"median":-17.625827,"eighty":-12.566149,"marketCap":1221621420},{"date":"2025-01-24","current":-27.866803,"twenty":-28.968769,"median":-17.665522,"eighty":-12.594815,"marketCap":1368371488},{"date":"2025-01-31","current":-25.768876,"twenty":-28.968769,"median":-17.692748,"eighty":-12.61273,"marketCap":1265354884},{"date":"2025-02-07","current":-23.591782,"twenty":-28.81744,"median":-17.719962,"eighty":-12.684394,"marketCap":1158450862},{"date":"2025-02-14","current":-23.7897,"twenty":-28.81245,"median":-17.725862,"eighty":-12.70231,"marketCap":1168169409},{"date":"2025-02-21","current":-22.245942,"twenty":-28.80529,"median":-17.742813,"eighty":-12.730975,"marketCap":1092364739},{"date":"2025-02-28","current":-20.741768,"twenty":-28.766646,"median":-17.750677,"eighty":-12.878556,"marketCap":1018503778},{"date":"2025-03-07","current":-21.474063,"twenty":-28.753554,"median":-17.783612,"eighty":-12.988431,"marketCap":1054462403},{"date":"2025-03-14","current":-23.492823,"twenty":-28.724796,"median":-17.918291,"eighty":-13.032048,"marketCap":1153591588},{"date":"2025-03-21","current":151.633005,"twenty":-28.645299,"median":-17.929848,"eighty":-12.988431,"marketCap":1212760777},{"date":"2025-03-28","current":153.227851,"twenty":-28.604711,"median":-17.78435,"eighty":-12.670061,"marketCap":1225516351},{"date":"2025-04-04","current":157.030944,"twenty":-28.551598,"median":-17.756493,"eighty":-12.515985,"marketCap":1255933491},{"date":"2025-04-11","current":172.365997,"twenty":-28.537065,"median":-17.742813,"eighty":-12.355333,"marketCap":1378583246},{"date":"2025-04-17","current":182.548472,"twenty":-28.53527,"median":-17.728408,"eighty":-12.28308,"marketCap":1460022683},{"date":"2025-04-25","current":168.930945,"twenty":-28.478265,"median":-17.719962,"eighty":-11.916185,"marketCap":1351109701},{"date":"2025-05-02","current":177.55989,"twenty":-28.413636,"median":-17.701176,"eighty":-11.620736,"marketCap":1420124003},{"date":"2025-05-09","current":165.034919,"twenty":-28.363303,"median":-17.672598,"eighty":-11.047488,"marketCap":1319949281},{"date":"2025-05-16","current":-85.348526,"twenty":-28.478265,"median":-17.679674,"eighty":-10.985179,"marketCap":1335704429},{"date":"2025-05-23","current":-91.122103,"twenty":-28.610323,"median":-17.701176,"eighty":-11.047488,"marketCap":1426060905},{"date":"2025-05-30","current":-97.209461,"twenty":-28.755493,"median":-17.719962,"eighty":-11.103567,"marketCap":1521328059},{"date":"2025-06-06","current":-84.344425,"twenty":-28.908237,"median":-17.728408,"eighty":-11.22507,"marketCap":1319990259},{"date":"2025-06-13","current":-90.369027,"twenty":-29.139819,"median":-17.742813,"eighty":-11.433807,"marketCap":1414275278},{"date":"2025-06-20","current":-99.845224,"twenty":-29.414401,"median":-17.756493,"eighty":-11.620736,"marketCap":1562577755},{"date":"2025-06-27","current":-113.463334,"twenty":-29.625971,"median":-17.78435,"eighty":-11.639429,"marketCap":1775701182},{"date":"2025-07-03","current":-103.673356,"twenty":-29.970507,"median":-17.918291,"eighty":-11.714201,"marketCap":1622488027},{"date":"2025-07-11","current":-112.835772,"twenty":-30.109473,"median":-17.96922,"eighty":-11.833393,"marketCap":1765879826},{"date":"2025-07-18","current":-115.157754,"twenty":-30.373971,"median":-18.060207,"eighty":-11.83882,"marketCap":1802218844},{"date":"2025-07-25","current":-112.459234,"twenty":-30.612951,"median":-18.156476,"eighty":-11.967761,"marketCap":1759987013},{"date":"2025-08-01","current":-110.953084,"twenty":-30.649879,"median":-18.318793,"eighty":-12.05734,"marketCap":1736415758},{"date":"2025-08-08","current":-110.764815,"twenty":-30.849578,"median":-18.491503,"eighty":-12.236498,"marketCap":1733469351},{"date":"2025-08-15","current":-29.781475,"twenty":-31.056082,"median":-18.779127,"eighty":-12.27233,"marketCap":1430017096},{"date":"2025-09-05","current":-22.001657,"twenty":-31.011769,"median":-19.029654,"eighty":-12.286663,"marketCap":1056453542},{"date":"2025-09-12","current":-20.890254,"twenty":-30.966274,"median":-19.71207,"eighty":-12.321272,"marketCap":1003087320},{"date":"2025-09-19","current":-20.43746,"twenty":-30.871196,"median":-20.12152,"eighty":-12.329028,"marketCap":981345526},{"date":"2025-09-26","current":-19.63478,"twenty":-30.797693,"median":-20.134768,"eighty":-12.355333,"marketCap":942803254},{"date":"2025-10-03","current":-21.157814,"twenty":-30.698248,"median":-20.149319,"eighty":-12.390575,"marketCap":1015934744},{"date":"2025-10-10","current":-23.833413,"twenty":-30.67,"median":-20.178749,"eighty":-12.426406,"marketCap":1144408982},{"date":"2025-10-17","current":-20.807928,"twenty":-30.653572,"median":-20.2775,"eighty":-12.47657,"marketCap":999134267},{"date":"2025-10-24","current":-19.861177,"twenty":-30.649879,"median":-20.299599,"eighty":-12.515985,"marketCap":953674152},{"date":"2025-10-31","current":-17.74128,"twenty":-30.620337,"median":-20.187599,"eighty":-12.551817,"marketCap":851883024},{"date":"2025-11-07","current":-16.866565,"twenty":-30.612951,"median":-20.149319,"eighty":-12.587649,"marketCap":809881831},{"date":"2025-11-14","current":-10.386267,"twenty":-30.612951,"median":-20.12152,"eighty":-12.426406,"marketCap":831316818},{"date":"2025-11-21","current":-8.311484,"twenty":-30.553867,"median":-19.933213,"eighty":-12.321272,"marketCap":665251152},{"date":"2025-11-28","current":-11.781806,"twenty":-30.491905,"median":-19.75827,"eighty":-12.164835,"marketCap":943015748},{"date":"2025-12-05","current":-12.312852,"twenty":-30.408561,"median":-19.63478,"eighty":-11.836649,"marketCap":985520651},{"date":"2025-12-12","current":-13.856589,"twenty":-30.373971,"median":-19.314339,"eighty":-11.916185,"marketCap":1109081415},{"date":"2025-12-19","current":-12.127603,"twenty":-30.309116,"median":-19.029654,"eighty":-12.021508,"marketCap":970693360},{"date":"2025-12-26","current":-14.177687,"twenty":-30.256997,"median":-18.779127,"eighty":-12.085445,"marketCap":1134782054},{"date":"2026-01-02","current":-14.387635,"twenty":-30.230821,"median":-18.672648,"eighty":-12.149382,"marketCap":1151586318},{"date":"2026-01-09","current":-13.523142,"twenty":-30.165419,"median":-18.491503,"eighty":-12.241889,"marketCap":1082392290},{"date":"2026-01-16","current":-13.696041,"twenty":-30.101841,"median":-18.441052,"eighty":-12.263452,"marketCap":1096231095},{"date":"2026-01-23","current":-13.053846,"twenty":-30.071312,"median":-18.318793,"eighty":-12.263452,"marketCap":1044829818},{"date":"2026-01-30","current":-12.621599,"twenty":-30.016829,"median":-18.156476,"eighty":-12.27233,"marketCap":1010232804},{"date":"2026-02-06","current":-11.942355,"twenty":-30.006457,"median":-18.060207,"eighty":-12.27233,"marketCap":955866068},{"date":"2026-02-13","current":-10.880263,"twenty":-29.970507,"median":-17.96922,"eighty":-12.251102,"marketCap":870856262},{"date":"2026-02-20","current":-11.658307,"twenty":-29.864079,"median":-17.933958,"eighty":-12.08391,"marketCap":933130887},{"date":"2026-02-27","current":-11.534808,"twenty":-29.792674,"median":-17.810106,"eighty":-11.837735,"marketCap":923246026},{"date":"2026-03-06","current":-11.26311,"twenty":-29.719333,"median":-17.772592,"eighty":-11.771926,"marketCap":901499332},{"date":"2026-03-13","current":-4.776529,"twenty":-29.651913,"median":-17.742813,"eighty":-11.650793,"marketCap":818209809},{"date":"2026-03-20","current":-4.782325,"twenty":-29.587058,"median":-17.742047,"eighty":-11.574328,"marketCap":819202782},{"date":"2026-03-27","current":-4.962025,"twenty":-29.539497,"median":-17.728408,"eighty":-11.403899,"marketCap":849984947},{"date":"2026-04-02","current":-4.701171,"twenty":-29.515414,"median":-17.719962,"eighty":-11.300637,"marketCap":805301159},{"date":"2026-04-10","current":-4.793919,"twenty":-29.472136,"median":-17.701176,"eighty":-11.16712,"marketCap":821188728},{"date":"2026-04-17","current":-4.741748,"twenty":-29.342914,"median":-17.679674,"eighty":-11.054765,"marketCap":812251971},{"date":"2026-04-24","current":-4.811309,"twenty":-29.218388,"median":-17.626125,"eighty":-10.944483,"marketCap":824167648},{"date":"2026-05-01","current":-4.788122,"twenty":-29.176877,"median":-17.592246,"eighty":-10.860503,"marketCap":820195755},{"date":"2026-05-08","current":-5.217082,"twenty":-29.123341,"median":-17.508842,"eighty":-10.149584,"marketCap":893675763},{"date":"2026-05-15","current":-4.602781,"twenty":-29.051193,"median":-17.430851,"eighty":-10.056766,"marketCap":788447224},{"date":"2026-05-22","current":-4.128106,"twenty":-29.025066,"median":-17.419754,"eighty":-9.920468,"marketCap":817265846},{"date":"2026-05-29","current":-4.714969,"twenty":-29.002547,"median":-17.374861,"eighty":-9.799739,"marketCap":933450662},{"date":"2026-06-05","current":-4.549443,"twenty":-28.908237,"median":-17.313866,"eighty":-9.477287,"marketCap":900680586},{"date":"2026-06-12","current":-4.810271,"twenty":-28.815444,"median":-17.262136,"eighty":-9.284127,"marketCap":952318282},{"date":"2026-06-18","current":-4.965765,"twenty":-28.81066,"median":-17.21396,"eighty":-9.20624,"marketCap":983102293},{"date":"2026-06-26","current":-4.022771,"twenty":-28.794286,"median":-17.19688,"eighty":-8.798113,"marketCap":796412161},{"date":"2026-07-02","current":-3.982644,"twenty":-28.757432,"median":-17.177383,"eighty":-8.749905,"marketCap":788467900},{"date":"2026-07-10","current":-3.952548,"twenty":-28.752585,"median":-17.10772,"eighty":-8.311484,"marketCap":782509704},{"date":"2026-07-17","current":-3.741879,"twenty":-28.717849,"median":-17.021402,"eighty":-8.1314,"marketCap":740802334},{"date":"2026-07-24","current":-3.009555,"twenty":-28.627161,"median":-16.884919,"eighty":-8.115823,"marketCap":595819572},{"date":"2026-07-31","current":-2.823965,"twenty":-28.604711,"median":-16.872443,"eighty":-8.050398,"marketCap":559077365},{"date":"2026-08-07","current":-2.783838,"twenty":-28.551598,"median":-16.842675,"eighty":-7.822968,"marketCap":551133104},{"date":"2026-08-14","current":-3.064153,"twenty":-28.537065,"median":-16.689461,"eighty":-7.495842,"marketCap":606628792},{"date":"2026-08-21","current":-2.541208,"twenty":-28.534893,"median":-16.6288,"eighty":-7.404552,"marketCap":547457623}],"updateTime":1787614885363},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPRY\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627794288","title":"ARS Pharmaceuticals Inc - Expect to File for Neffy 1 Mg Approval for Children 15-30 Kg in Canada by Summer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627794288","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627794288?lang=en_us&edition=fundamental","pubTime":"2026-04-15 18:05","pubTimestamp":1776247500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUA52DRST:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627292288","title":"Neffy® (Epinephrine Nasal Spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (Anaphylaxis)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627292288","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627292288?lang=en_us&edition=fundamental","pubTime":"2026-04-15 18:05","pubTimestamp":1776247500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUA52DRST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627227514","title":"Analysts Are Bullish on These Healthcare Stocks: ARS Pharmaceuticals (SPRY), Longeveron (LGVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627227514","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627227514?lang=en_us&edition=fundamental","pubTime":"2026-04-15 05:20","pubTimestamp":1776201612,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ARS Pharmaceuticals (SPRY), Longeveron (LGVN) and In...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-ars-pharmaceuticals-spry-longeveron-lgvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-ars-pharmaceuticals-spry-longeveron-lgvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0029874061.USD","BLSG","XBI","SPRY","BK4137","BK4581","LGVN","BK4112","BK4139","LABU","BK4588","BLSX","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626181623","title":"ARS Pharmaceuticals Inc : Northland Capital Initiates Coverage With Outperform Rating; Target Price $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2626181623","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626181623?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:45","pubTimestamp":1775735156,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40S0OJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626904357","title":"U.S. RESEARCH ROUNDUP-Comstock Resources, Trustmark, Viasat","url":"https://stock-news.laohu8.com/highlight/detail?id=2626904357","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626904357?lang=en_us&edition=fundamental","pubTime":"2026-04-09 15:50","pubTimestamp":1775721049,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Comstock Resources, Trustmark, ViasatApril 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Comst","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nL8N40S0B7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGL","BMY","BX","BRO","CONL","CME","CTVA","CVNX","CG","APD","ALLY","ASRT","AMG","COTG","COF","CVNA","EL","ARES","AMGN","ARRY","BWIN","CC","APO","AXPG","SCHW","TRMK","CHD","CE","ADTN","ALB","SPRY","CL","CHRD","AXP","COHR","COIN","CAT","ASTS","AEE","AFL","CONI","COST","CBOE","BLK","COSW","CRK","APH","ALBG","AA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622294128","title":"ARS Gets FDA Approval to Remove Age Requirement for Allergic-Reaction Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2622294128","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622294128?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:27","pubTimestamp":1774614420,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals received approval from the Food and Drug Administration to remove the age requirement for its neffy nasal spray to treat allergic reactions.Children were previously required to be at least four years old to receive the 1 milligram dose of the spray.All children and adults who weigh at least 33 pounds will now be able to use it.\"Caregivers often face tremendous fear administering needle-based treatment options but now, neffy can be used safely in our most vulnerable young patients,\" said Chief Executive Richard Lowenthal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LABU","BK4585","SPRY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622291518","title":"ARS Pharmaceuticals receives FDA approval to remove neffy 1 mg age requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2622291518","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622291518?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:16","pubTimestamp":1774613784,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals (SPRY) announced that the FDA has approved updating the neffy 1 mg prescribing information to remove the age criteria so all ch...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ars-pharmaceuticals-receives-fda-approval-to-remove-neffy-1-mg-age-requirement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ars-pharmaceuticals-receives-fda-approval-to-remove-neffy-1-mg-age-requirement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","SPRY","BK4139","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622826037","title":"BRIEF-Ars Pharmaceuticals Receives FDA Approval To Remove Age Requirement From Neffy® 1 Mg (Epinephrine Nasal Spray) Label","url":"https://stock-news.laohu8.com/highlight/detail?id=2622826037","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622826037?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:07","pubTimestamp":1774613231,"startTime":"0","endTime":"0","summary":"BRIEF-Ars Pharmaceuticals Receives FDA Approval To Remove Age Requirement From Neffy 1 Mg (Epinephrine Nasal Spray) LabelARS Pharmaceuticals Inc SPRY.O:ARS PHARMACEUTICALS RECEIVES FDA APPROVAL TO REM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nTUA11RQ7Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618621668","title":"ARS Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2618621668","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618621668?lang=en_us&edition=fundamental","pubTime":"2026-03-09 21:31","pubTimestamp":1773063076,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings SummaryARS Pharmaceuticals Inc SPRY.OQ reported a quarterly adjusted loss of 42 cents per share for the quarter end","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL8N3ZX1BW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618640761","title":"BRIEF-ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2618640761","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618640761?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:05","pubTimestamp":1773054308,"startTime":"0","endTime":"0","summary":"BRIEF-ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results March 9 (Reuters) - ARS Pharmaceuticals Inc SPRY.O:ARS PHARMACEUTICALS Q4 EPS USD -0.42ARS PHARMACEUTICALS Q4 NET ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nPLXB50D2B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618771642","title":"ARS Pharmaceuticals Reports Q4 Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2618771642","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618771642?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:18","pubTimestamp":1773051523,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals (SPRY) reported a Q4 net loss Monday of $0.42 per diluted share.Three analysts surveyed by FactSet expected a loss of $0.39.Revenue for the quarter ended Dec. 31 was $28.1 million.Analysts surveyed by FactSet expected revenue of $25.6 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618764222","title":"Earnings Flash (SPRY) ARS Pharmaceuticals Posts Q4 Net Loss $0.42 a Share, vs. FactSet Est of $0.39 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2618764222","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618764222?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:16","pubTimestamp":1773051379,"startTime":"0","endTime":"0","summary":"Earnings Flash (SPRY) ARS Pharmaceuticals Posts Q4 Net Loss $0.42 a Share, vs. FactSet Est of $0.39 Loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","SPRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618642108","title":"ARS Pharmaceuticals Q4 revenue beats expectations on strong neffy sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2618642108","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618642108?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:10","pubTimestamp":1773051002,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Q4 revenue beats expectations on strong neffy salesOverviewBiopharmaceutical firm's Q4 revenue beat analyst expectationsCompany reported Q4 net loss of $41.3 mlnCompany holds $245 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL1N3ZX0CN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","SPRY","BK4139","LU0203347892.USD","LU0154245673.USD","BK4533","BK4588","LU0154245756.USD","LU0203345920.USD","CMI","BK4585","BK4149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618642540","title":"ARS Pharmaceuticals FY2025 net product revenue rose 895% to USD 72.19 million as net loss widened to USD 171.3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618642540","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618642540?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:00","pubTimestamp":1773050452,"startTime":"0","endTime":"0","summary":"ARS Pharma reported Q4 2025 total revenue of USD 28.1 million, including USD 20.3 million in U.S. net product revenue from neffy. Q4 2025 net loss was USD 41.3 million, or USD 0.42 per share . For FY 2025, total revenue was USD 84.28 million, including USD 72.2 million in U.S. net product revenue from neffy. FY 2025 net loss was USD 171.3 million, or USD 1.74 per share . ARS Pharma ended 2025 with USD 245 million in cash, cash equivalents and short-term investments, and said it plans to expand its sales force to 150 from 106 starting in Q2 2026 while keeping 2026 SG&A spending at a similar annualized level.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL5wQ12Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SPRY","BK4588","IE00BKPKM429.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","NDAQ","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014021.USD","LU0314104364.USD","BK4139","SG9999014005.SGD","LU2210150020.SGD","SG9999014039.USD","BK4585","BK4112","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618864255","title":"ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on Neffy® (Epinephrine Nasal Spray) Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2618864255","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618864255?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:00","pubTimestamp":1773050401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nTUA4PS3LV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618642584","title":"ARS Pharmaceuticals Inc: Neffy Delivers $72.2 Mln of U.S. Net Product Revenue in First Full Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2618642584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618642584?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:00","pubTimestamp":1773050401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nTUA4PS3LV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618642546","title":"ARS Pharmaceuticals Inc - ARS Pharma to Expand Sales Force From 106 to 150 Beginning Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618642546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618642546?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:00","pubTimestamp":1773050401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nPLXB50D2B:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618642511","title":"ARS Pharmaceuticals Inc - Regulatory Approval for Neffy in Canada Expected Q2 2026, Launch Expected Later in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618642511","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618642511?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:00","pubTimestamp":1773050401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nPLXB50D2B:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618464255","title":"ARS Pharmaceuticals Q4 Revenue USD 28.1 Million VS. Ibes Estimate USD 25.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618464255","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618464255?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:00","pubTimestamp":1773050401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nPLXB50D2B:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618528642","title":"Press Release: ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy(R) (epinephrine nasal spray) Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2618528642","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618528642?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:00","pubTimestamp":1773050400,"startTime":"0","endTime":"0","summary":"neffy delivers $72.2 million of U.S. net product revenue in first full year. Intranasal epinephrine platform advances with Phase 2b CSU data expected mid-2026. Strong balance sheet of $245.0 million in cash, cash equivalents and short-term investments supports operating plan through anticipated cash-flow break-even. \"2025 was an important year for ARS Pharma as we established neffy as a differentiated, scalable epinephrine treatment of choice. We have built a strong base business with initial prescriptions expected to begin renewing in 2026 as product reaches expiration. This shift towards renewals, combined with continued growth in new neffy patients, positions us to accelerate market share expansion,\" said Richard Lowenthal, Co-Founder, President and CEO of ARS Pharma.and $0.9 million in supply revenue from partners. The cash value of. and $0.1 million was recorded to the financing liability on the company's. collaboration revenue, and $2.4 million from supply agreements. The cash","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHMP","BK4081","BK4087","BK4232","BK4500","BK4008","BK4139","SPRY","BK4585","ALK","EMA","BK4588","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":83,"code":"91000000","status":"200"}]}}